Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sebastián García Martí is active.

Publication


Featured researches published by Sebastián García Martí.


BMC Public Health | 2010

Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina

Adolfo Rubinstein; Lisandro D. Colantonio; Ariel Bardach; Joaquín Caporale; Sebastián García Martí; Karin Kopitowski; Andrea Alcaraz; Luz Gibbons; Federico Augustovski; Andres Pichon-Riviere

BackgroundCardiovascular disease (CVD) is the primary cause of mortality and morbidity in Argentina representing 34.2% of deaths and 12.6% of potential years of life lost (PYLL). The aim of the study was to estimate the burden of acute coronary heart disease (CHD) and stroke and the cost-effectiveness of preventative population-based and clinical interventions.MethodsAn epidemiological model was built incorporating prevalence and distribution of high blood pressure, high cholesterol, hyperglycemia, overweight and obesity, smoking, and physical inactivity, obtained from the Argentine Survey of Risk Factors dataset. Population Attributable Fraction (PAF) of each risk factor was estimated using relative risks from international sources. Total fatal and non-fatal events, PYLL and Disability Adjusted Life Years (DALY) were estimated. Costs of event were calculated from local utilization databases and expressed in international dollars (I


Cost Effectiveness and Resource Allocation | 2009

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Adolfo Rubinstein; Sebastián García Martí; Alberto Souto; Daniel Ferrante; Federico Augustovski

). Incremental cost-effectiveness ratios (ICER) were estimated for six interventions: reducing salt in bread, mass media campaign to promote tobacco cessation, pharmacological therapy of high blood pressure, pharmacological therapy of high cholesterol, tobacco cessation therapy with bupropion, and a multidrug strategy for people with an estimated absolute risk > 20% in 10 years.ResultsAn estimated total of 611,635 DALY was lost due to acute CHD and stroke for 2005. Modifiable risk factors explained 71.1% of DALY and more than 80% of events. Two interventions were cost-saving: lowering salt intake in the population through reducing salt in bread and multidrug therapy targeted to persons with an absolute risk above 20% in 10 years; three interventions had very acceptable ICERs: drug therapy for high blood pressure in hypertensive patients not yet undergoing treatment (I


International Journal of Technology Assessment in Health Care | 2010

Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America?

Andres Pichon-Riviere; Federico Augustovski; Adolfo Rubinstein; Sebastián García Martí; Sean D. Sullivan; Michael Drummond

2,908 per DALY saved), mass media campaign to promote tobacco cessation amongst smokers (I


Vaccine | 2010

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.

Sandra E. Talbird; Thomas N. Taylor; Stefanie Knoll; Carl Richard Frostad; Sebastián García Martí

3,186 per DALY saved), and lowering cholesterol with statin drug therapy (I


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2010

Estimación de la carga de las enfermedades cardiovasculares atribuible a factores de riesgo modificables en Argentina

Adolfo Rubinstein; Lisandro D. Colantonio; Ariel Bardach; Joaquín Caporale; Sebastián García Martí; Karin Kopitowski; Andrea Alcaraz; Luz Gibbons; Federico Augustovski; Andres Pichon-Riviere

14,432 per DALY saved); and one intervention was not found to be cost-effective: tobacco cessation with bupropion (I


International Journal of Technology Assessment in Health Care | 2012

Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers.

Andres Pichon-Riviere; Federico Augustovski; Sebastián García Martí; Sean D. Sullivan; Michael Drummond

59,433 per DALY saved)ConclusionsMost of the interventions selected were cost-saving or very cost-effective. This study aims to inform policy makers on resource-allocation decisions to reduce the burden of CVD in Argentina.


Pediatric Infectious Disease Journal | 2014

Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the Caribbean: a systematic review and meta-analysis.

Agustín Ciapponi; Natalia Elorriaga; Juan Ignacio Rojas; Marina Romano; Sebastián García Martí; Ariel Bardach; Silvina Ruvinsky

BackgroundChronic diseases, represented mainly by cardiovascular disease (CVD) and cancer, are increasing in developing countries and account for 53% of chronic diseases in Argentina. There is strong evidence that a reduction of 50% of the deaths due to CVD can be attributed to a reduction in smoking, hypertension and hypercholesterolemia. Generalized cost-effectiveness analysis (GCE) is a methodology designed by WHO to inform decision makers about the extent to which current or new interventions represent an efficient use of resources. We aimed to use GCE analysis to identify the most efficient interventions to decrease CVD.MethodsSix individual interventions (treatment of hypertension, hypercholesterolemia, smoking cessation and combined clinical strategies to reduce the 10 year CVD Risk) and two population-based interventions (cooperation between government, consumer associations and bakery chambers to reduce salt in bread, and mass education strategies to reduce hypertension, hypercholesterolemia and obesity) were selected for analysis. Estimates of effectiveness were entered into age and sex specific models to predict their impact in terms of age-weighted and discounted DALYs saved (disability-adjusted life years). To translate the age- and sex-adjusted incidence of CVD events into health changes, we used risk model software developed by WHO (PopMod). Costs of services were measured in Argentine pesos, and discounted at an annual rate of 3%. Different budgetary impact scenarios were explored.ResultsThe average cost-effectiveness ratio in argentine pesos (ARS


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2009

Childhood pneumococcal disease burden in Argentina.

Federico Augustovski; Sebastián García Martí; Andres Pichon-Riviere; Roberto Debbag

) per DALY for the different interventions were: (i) less salt in bread


Expert Review of Pharmacoeconomics & Outcomes Research | 2015

Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences

Federico Augustovski; Andrea Alcaraz; Joaquín Caporale; Sebastián García Martí; Andrés Pichón Riviere

151; (ii) mass media campaign


Expert Review of Pharmacoeconomics & Outcomes Research | 2010

Economic evaluations on cardiovascular preventive interventions in Argentina.

Lisandro D. Colantonio; Sebastián García Martí; Adolfo Rubinstein

547; (iii) combination drug therapy provided to subjects with a 20%, 10% and 5% global CVD risk,

Collaboration


Dive into the Sebastián García Martí's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ariel Bardach

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Andrea Alcaraz

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joaquín Caporale

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Adolfo Rubinstein

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Lisandro D. Colantonio

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Natalie Soto

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Fernando Rubinstein

Hospital Italiano de Buenos Aires

View shared research outputs
Researchain Logo
Decentralizing Knowledge